84 programming-"the"-"DAAD"-"UCL"-"U"-"SciLifeLab"-"U.S"-"Prof"-"https:" "University of Southampton" positions in United Kingdom
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Future Climate (MFC). This is an exciting joint venture between the University of Reading, Imperial College London and the University of Southampton. You will be a part of the Department of Mathematics and
-
creative excellence. Working at the University of Southampton: Check out the staff benefits and why you should join us at The University of Southampton.
-
. The University of Southampton offers a generous annual leave package including additional closure days (pro-rata for part time staff). The Faculty of Medicine holds an Athena SWAN Silver Award demonstrating
-
creative excellence. Working at the University of Southampton: Check out the staff benefits and why you should join us at The University of Southampton.
-
: Monday – Thursday 13:45-20:15 Working at the University of Southampton: Check out the staff benefits and why you should join us at The University of Southampton!
-
the laboratory of Professors Ward and Ober. Their interdisciplinary research program is dedicated to the development of novel antibody-based therapeutics that has led to several therapeutics that are currently in
-
Be part of the world-renowned WorldPop Research Programme at the University of Southampton (UoS), a global top 100 university (QS World Rankings 2021). WorldPop is a global, award winning, multi
-
. This role will be based at LifeLab at University Hospital Southampton. This is a full-time (1.0 FTE), fixed-term appointment for 12 months in the first instance. This role is subject to appointment on Spinal
-
. This role will be based at LifeLab at University Hospital Southampton. This is a full-time (1.0 FTE), fixed-term appointment for 12 months in the first instance. This role is subject to appointment on Spinal
-
the laboratory of Professors Ward and Ober. Their interdisciplinary research program is dedicated to the development of novel antibody-based therapeutics that has led to several therapeutics that are currently in